Original language | English |
---|---|
Pages (from-to) | 813-823 |
Journal | The Lancet Oncology |
Volume | 22 |
Issue number | 6 |
DOIs | |
Publication status | Published - 1 Jun 2021 |
Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study
Martin J Van den bent, C Mircea S Tesileanu, Wolfgang Wick, Marc Sanson, Alba Ariela Brandes, Paul M Clement, Sarah Erridge, Michael A Vogelbaum, Anna K Nowak, Jean Français Baurain, Warren P Mason, Helen Wheeler, Olivier L Chinot, Sanjeev Gill, Matthew Griffin, Leland Rogers, Walter Taal, Roberta Rudà, Michael Weller, Catherine Mcbain
Research output: Contribution to journal › Article › peer-review